- Home
- GAN vs UNCY Comparison
GAN vs UNCY Comparison
Compare GAN & UNCY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GAN
- UNCY
- Stock Information
- Founded
- GAN 1999
- UNCY 2016
- Country
- GAN United States
- UNCY United States
- Employees
- GAN N/A
- UNCY N/A
- Industry
- GAN Computer Software: Programming Data Processing
- UNCY Biotechnology: Pharmaceutical Preparations
- Sector
- GAN Technology
- UNCY Health Care
- Exchange
- GAN Nasdaq
- UNCY Nasdaq
- Market Cap
- GAN 83.2M
- UNCY 70.3M
- IPO Year
- GAN 2020
- UNCY 2021
- Fundamental
- Price
- GAN $1.84
- UNCY $0.62
- Analyst Decision
- GAN
- UNCY Strong Buy
- Analyst Count
- GAN 0
- UNCY 4
- Target Price
- GAN N/A
- UNCY $5.50
- AVG Volume (30 Days)
- GAN 218.4K
- UNCY 1.3M
- Earning Date
- GAN 03-12-2025
- UNCY 11-13-2024
- Dividend Yield
- GAN N/A
- UNCY N/A
- EPS Growth
- GAN N/A
- UNCY N/A
- EPS
- GAN N/A
- UNCY N/A
- Revenue
- GAN $134,024,000.00
- UNCY N/A
- Revenue This Year
- GAN $5.97
- UNCY N/A
- Revenue Next Year
- GAN $11.32
- UNCY N/A
- P/E Ratio
- GAN N/A
- UNCY N/A
- Revenue Growth
- GAN N/A
- UNCY N/A
- 52 Week Low
- GAN $1.17
- UNCY $0.20
- 52 Week High
- GAN $1.87
- UNCY $1.82
- Technical
- Relative Strength Index (RSI)
- GAN 53.95
- UNCY 40.04
- Support Level
- GAN $1.81
- UNCY $0.61
- Resistance Level
- GAN $1.85
- UNCY $0.73
- Average True Range (ATR)
- GAN 0.02
- UNCY 0.07
- MACD
- GAN 0.00
- UNCY -0.02
- Stochastic Oscillator
- GAN 75.00
- UNCY 15.66
About GAN GAN Limited
GAN Ltd provides Software-as-a-Service solutions for online casino gaming and sports betting applications. The company has two operating segments B2B and B2C. The B2B segment develops, markets, and sells instances of GameSTACK, GAN Sports, and iSight Back Office technology that incorporates comprehensive player registration, account funding, and back-office accounting and management tools that enable the casino operators to efficiently, confidently, and effectively extend their presence online in places that have permitted online real money gaming, and The B2C segment, which includes the operations of Coolbet, develops and operates a B2C online sports betting and casino platform that is accessible through its website in markets across Northern Europe, Latin America, and Canada.
About UNCY Unicycive Therapeutics Inc.
Unicycive Therapeutics Inc is a biotechnology company dedicated to developing treatments for certain medical conditions. It is focusing on kidney diseases. The company's lead drug, Renazorb, is a novel phosphate-binding agent being developed for the treatment of hyperphosphatemia. Unicycive's other drug, UNI-494, is a new chemical entity with the issued composition of matter patent protection in late preclinical development for the treatment of acute kidney injury.